Board Certified Neurosurgeon Joins DHR Health Neuroscience Institute  

Translate to Spanish or other 102 languages!

Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source:  googlemaps
Dr. Inad B. Atassi Brings Exceptional Neurological Experience to the Rio Grande Valley. Courtesy Image. BGD Image Source: googlemaps

Mega Doctor News

- Advertisement -

Edinburg, TX – The DHR Health Neuroscience Institute is pleased to welcome Inad B. Atassi, M.D, F.A.C.S., to the team. Utilizing the most advanced surgical techniques to provide comprehensive neurological care to patients, Dr. Atassi specializes in the treatment of brain tumors, spinal cord tumors, stroke and traumatic head & spine injuries.

Dr. Atassi is Board Certified in Neurosurgery and brings more than 35 years of experience in the field to patients of the Rio Grande Valley. He received his Doctor of Medicine at Damascus University in Damascus, Syria. He completed his General Surgery residency at Henry Ford Hospital in Detroit, Michigan and continued his Neurosurgery residency training at the University of Kansas Medical Center in Kansas City, Kansas.

Dr. Atassi has been in private practice, as well as worked in clinics and hospitals around the world providing neurologic care to adult and pediatric patients before bringing his talents to South Texas in 2020.He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, American College of Surgeons, North Carolina Medical Society, Cumberland County Medical Society, and North American Spine Society.

- Advertisement -

To schedule an appointment with Dr. Atassi, please call (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Social Security Administration Corrects Millions of Records in Major Database Cleanup

The Social Security Administration (SSA) announced on October 20, 2026, that it has corrected millions of Social Security number records in what the agency describes as its most comprehensive record-integrity initiative in 91 years.

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

A UTHealth Houston Physician Turned a Texas Teen’s Frightening Diagnosis into a Champion Title

Two years ago, Geordon Boulware, now 15, was at a routine dental visit in his hometown of Lufkin, Texas, when his dentist discovered he had an abnormal growth on his jaw. After meeting with a local oral surgeon, Geordon and his mom decided to seek treatment in Houston. 

Dr. Lisa Chapa Explains Why Not Every Breast Lump Is Cancer

 Discovering a lump in the breast can cause immediate concern, but many breast abnormalities are not cancerous, according to Dr. Lisa Chapa, a breast surgeon who explained how physicians distinguish benign conditions from breast cancer.
- Advertisement -